[go: up one dir, main page]

WO2020112059A3 - The delayed release capsule comprising dimethyl fumarate - Google Patents

The delayed release capsule comprising dimethyl fumarate Download PDF

Info

Publication number
WO2020112059A3
WO2020112059A3 PCT/TR2019/050964 TR2019050964W WO2020112059A3 WO 2020112059 A3 WO2020112059 A3 WO 2020112059A3 TR 2019050964 W TR2019050964 W TR 2019050964W WO 2020112059 A3 WO2020112059 A3 WO 2020112059A3
Authority
WO
WIPO (PCT)
Prior art keywords
dimethyl fumarate
delayed release
release capsule
fumarate
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2019/050964
Other languages
French (fr)
Other versions
WO2020112059A2 (en
Inventor
Ali Turkyilmaz
Arzu PALANTOKEN
Fatih MOLLAOGLU
Dicle GUNER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Priority to EP19888384.5A priority Critical patent/EP3886835A4/en
Publication of WO2020112059A2 publication Critical patent/WO2020112059A2/en
Publication of WO2020112059A3 publication Critical patent/WO2020112059A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a delayed release capsule comprising dimethyl fumarate and at least one pharmaceutically acceptable excipient wherein the particle size d (0.8) of dimethyl fumarate is less than 250 µm.
PCT/TR2019/050964 2018-11-30 2019-11-18 The delayed release capsule comprising dimethyl fumarate Ceased WO2020112059A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19888384.5A EP3886835A4 (en) 2018-11-30 2019-11-18 DELAYED RELEASE CAPSULE WITH DIMETHYL FUMARATE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2018/18293A TR201818293A2 (en) 2018-11-30 2018-11-30 The delayed release capsule comprising dimethyl fumarate
TR2018/18293 2018-11-30

Publications (2)

Publication Number Publication Date
WO2020112059A2 WO2020112059A2 (en) 2020-06-04
WO2020112059A3 true WO2020112059A3 (en) 2020-08-13

Family

ID=70854336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050964 Ceased WO2020112059A2 (en) 2018-11-30 2019-11-18 The delayed release capsule comprising dimethyl fumarate

Country Status (3)

Country Link
EP (1) EP3886835A4 (en)
TR (1) TR201818293A2 (en)
WO (1) WO2020112059A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013119677A1 (en) * 2012-02-07 2013-08-15 Biogen Idec Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
WO2016113754A2 (en) * 2015-01-14 2016-07-21 Leiutis Pharmaceuticals Pvt, Ltd. Novel oral dosage forms of dimethyl fumarate
WO2017145036A1 (en) * 2016-02-25 2017-08-31 Aurobindo Pharma Ltd Pharmaceutical compositions comprising dimethyl fumarate
EP3326653A1 (en) * 2016-11-23 2018-05-30 Sanovel Ilac Sanayi ve Ticaret A.S. Delayed release dosage forms comprising dimethyl fumarate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE14172396T1 (en) * 2004-10-08 2015-01-08 Forward Pharma A/S Controlled release of pharmaceutical compositions with fumaric acid ester
US9326947B1 (en) * 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
JP2018517735A (en) * 2015-06-17 2018-07-05 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Dimethyl fumarate particles and pharmaceutical compositions thereof
GR1009149B (en) * 2016-10-25 2017-10-31 Φαρματεν Αβεε PHARMACEUTICAL PARTICULARS CONTAINING A FUMAR ACID ESTER AND METHOD OF PRODUCTION thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013119677A1 (en) * 2012-02-07 2013-08-15 Biogen Idec Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
WO2016113754A2 (en) * 2015-01-14 2016-07-21 Leiutis Pharmaceuticals Pvt, Ltd. Novel oral dosage forms of dimethyl fumarate
WO2017145036A1 (en) * 2016-02-25 2017-08-31 Aurobindo Pharma Ltd Pharmaceutical compositions comprising dimethyl fumarate
EP3326653A1 (en) * 2016-11-23 2018-05-30 Sanovel Ilac Sanayi ve Ticaret A.S. Delayed release dosage forms comprising dimethyl fumarate

Also Published As

Publication number Publication date
EP3886835A4 (en) 2022-08-10
TR201818293A2 (en) 2020-06-22
EP3886835A2 (en) 2021-10-06
WO2020112059A2 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
USD1079706S1 (en) Lattice
USD809818S1 (en) Plant stand
WO2018189646A8 (en) AMORPHOUS FORM AND SOLID DISPERSIONS OF LUMATEPERONE p-TOSYLATE
EP4066931A4 (en) Biomagnetic microsphere and preparation method therefor and use thereof
WO2020104970A3 (en) Multi-layered particles
SG10201805657PA (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin
WO2019059557A3 (en) Medicinal composition comprising sglt-2 inhibitor and angiotensin receptor blocker
GB0204772D0 (en) Pharmaceutical dosage forms
IL314009B2 (en) Parp1 inhibitors and uses thereof
WO2016125190A3 (en) Novel crystalline forms of vortioxetine, premixes, and processes for the preparation thereof
WO2012087255A3 (en) Pharmaceutical formulations comprising imatinib
USD906693S1 (en) Paper product
WO2020112059A3 (en) The delayed release capsule comprising dimethyl fumarate
MX395521B (en) Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
EP3986870A4 (en) A novel crystalline form of olaparib and a process for preparing the same
WO2023113744A3 (en) A tablet formulation comprising micronized benidipine
HK1212917A1 (en) Dosage forms containing terbutaline sulphate
WO2011141708A3 (en) New particles of tetracyclines and protecting agent
WO2016091805A3 (en) Naloxone monopreparation and multi-layer tablet
WO2019240697A3 (en) Pharmaceutical compositions for parenteral administration comprising lacosamide
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
EP4438121A3 (en) Pharmaceutical composition containing acetominophen and ibuprofen
WO2020012408A3 (en) A process for purification of protected polycyclic carbamoylpyridone derivatives
WO2015070266A3 (en) Gem having a stellar appearance
EP3938370A4 (en) Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19888384

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019888384

Country of ref document: EP

Effective date: 20210630